Literature DB >> 3261869

Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

L V Rao1, S I Rapaport.   

Abstract

Whether the factor VII/tissue factor complex that forms in tissue factor-dependent blood coagulation must be activated to factor VIIa/tissue factor before it can activate its substrates, factor X and factor IX, has been a difficult question to answer because the substrates, once activated, back-activate factor VII. Our earlier studies suggested that human factor VII/tissue factor cannot activate factor IX. Studies have now been extended to the activation of factor X. Reaction mixtures were made with purified factor VII, X, and tissue factor; in some experiments antithrombin III and heparin were added to prevent back-activation of factor VII. Factor X was activated at similar rates in reaction mixtures containing either factor VII or factor VIIa after an initial 30-sec lag with factor VII. In reaction mixtures with factor VII a linear activation of factor X was established several minutes before cleavage of 125I-labeled factor VII to the two-chain activated molecule was demonstrable on gel profiles. Adding antithrombin III and heparin blocked activation of factor X by factor VII/tissue factor but not by factor VIIa/tissue factor. When the antithrombin III and heparin were added 1 min after the other reagents, factor VII/tissue factor activation of factor X was not blocked. These data suggest that factor VII/tissue factor cannot activate measurable amounts of factor X over several minutes. Overall, our results support the hypothesis that a rapid preferential activation of factor VII bound to tissue factor by trace amounts of factor Xa is a key early step in tissue factor-dependent blood coagulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261869      PMCID: PMC282042          DOI: 10.1073/pnas.85.18.6687

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor.

Authors:  S A Silverberg; Y Nemerson; M Zur
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

2.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Studies on the chemical and enzymatic modification of glycoproteins. A general method for the tritiation of sialic acid-containing glycoproteins.

Authors:  L Van Lenten; G Ashwell
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

4.  Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion.

Authors:  U Seligsohn; C K Kasper; B Osterud; S I Rapaport
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.

Authors:  M Zur; R D Radcliffe; J Oberdick; Y Nemerson
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

7.  Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor.

Authors:  M Zur; Y Nemerson
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

8.  Purification and properties of human coagulation factor VII.

Authors:  G J Broze; P W Majerus
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

9.  The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation.

Authors:  K A Bauer; R D Rosenberg
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

10.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.

Authors:  L T Mimms; G Zampighi; Y Nozaki; C Tanford; J A Reynolds
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more
  38 in total

1.  Fusion of two distinct peptide exosite inhibitors of Factor VIIa.

Authors:  Martin Roberge; Mark Peek; Daniel Kirchhofer; Mark S Dennis; Robert A Lazarus
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

Review 2.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells.

Authors:  Mari I Jonsson; Annasara E Lenman; Lars Frängsmyr; Cecilia Nyberg; Mohamed Abdullahi; Niklas Arnberg
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

5.  Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.

Authors:  S Dittmar; W Ruf; T S Edgington
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

6.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.

Authors:  Egon Persson; Helle Bak; Anette Østergaard; Ole H Olsen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

8.  Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.

Authors:  Pei Wang; Yunfei Wu; Xiaoming Li; Xiaofeng Ma; Liangwei Zhong
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

9.  Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.

Authors:  Jayashree Shanker; Ganapathy Perumal; Arindam Maitra; Veena S Rao; B K Natesha; Shibu John; Sridhar Hebbagodi; Vijay V Kakkar
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

10.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.